The global Guillain-Barré Syndrome (GBS) market is poised for significant growth over the coming years, with projections indicating an increase from USD 644.24 million in 2024 to USD 960.58 million by 2032, representing a robust CAGR of 5.1% during the forecast period. This surge is being fueled by rising awareness of neurological disorders, the growing prevalence of GBS, and the...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek